<?xml version="1.0" encoding="UTF-8"?>
<p>The elucidation of potential targets could lead to COVID-19-specific treatments (
 <xref ref-type="fig" rid="fig11-0300060520949077">Figure 11</xref>). Approaches to anti-SARS-CoV-2 drug development include (a) inhibition of SARS-CoV-2 entry, (b) disruption of SARS-CoV-2 
 <sup>+</sup>ssRNA synthesis after entry, (c) inflammatory response suppression, and (d) disruption of SARS-CoV-2 translation.
</p>
